Synapse - Sandra D'Angelo

Results (252)

First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): Primary and biomarker analyses of a phase II study

Journal Article

D'Angelo, S. P.; Lebbé, C.; Mortier, L.; Brohl, A. S.; Fazio, N.; Grob, J. J.; Prinzi, N.; Hanna, G. J.; Hassel, J. C.; Kiecker, F.; more...
Journal for ImmunoTherapy of Cancer (2021)

Fulltext@MSK | Save

Selinexor, a first in class, nuclear export inhibitor for the treatment of advanced malignant peripheral nerve sheath tumor

Journal Article

Al-Ezzi, E.; Gounder, M.; Watson, G.; Mazzocca, A.; D'Angelo, S. P.; Bravetti, J.; Wang, H.; Abdul Razak, A.; Vincenzi, B.
The Oncologist (2021)

Fulltext@MSK | Save

HLA genotyping in synovial sarcoma: Identifying HLA-A*02 and its association with clinical outcome

Meeting Abstract

Rosenbaum, E.; Seier, K.; Bandlamudi, C.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Movva, S.; Nacev, B.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Safety and activity of autologous T cells with enhanced NY-ESO-1-specific T-cell receptor (GSK3377794) in HLA-a*02(+) previously-treated and - untreated patients with advanced metastatic/unresectable synovial sarcoma: A master protocol study design (IGNYTE-ESO)

Meeting Abstract

D'Angelo, S. P.; Blay, J. Y.; Chow, W. A.; Demetri, G. D.; Thistlethwaite, F.; Sen, S.; Razak, A. R. A.; Haanen, J. B. A. G.; Noujaim, J. C.; Johnson, M. L.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

SPEARHEAD-1: A phase II trial of ADP-A2M4 SPEAR T cells in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma

Meeting Abstract

Araujo, D. M.; Druta, M.; Agulnik, M.; D'Angelo, S. P.; Blay, J. Y.; Strauss, S. J.; Valverde, C.; Razak, A. R. A.; Van Winkle, E.; Trivedi, T.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Phase Ia/Ib dose-escalation study of the anti-TIGIT antibody tiragolumab as a single agent and in combination with atezolizumab in patients with advanced solid tumors

Meeting Abstract

Bendell, J. C.; Bedard, P.; Bang, Y. J.; LoRusso, P.; Hodi, S.; Gordon, M.; D'Angelo, S.; Desai, J.; Garralda, E.; Italiano, A.; more...
Cancer Research (2020)

Fulltext@MSK | Save

Reveal: Phase 1 dose-escalation study of NKTR-262, a novel TLR7/8 agonist, plus bempegaldesleukin: Local innate immune activation and systemic adaptive immune expansion for treating solid tumors

Meeting Abstract

Diab, A.; Curti, B.; Bilen, M.; Brohl, A.; Domingo-Musibay, E.; Borazanci, E.; Fanton, C.; Haglund, C.; Vimal, M.; Muhsin, M.; more...
Journal for ImmunoTherapy of Cancer (2020)

Fulltext@MSK | Save

Final analysis of the phase 1 trial of NY-ESO-1-specific T-cell receptor (TCR) T-cell therapy (letetresgene autoleucel; GSK3377794) in patients with advanced synovial sarcoma (SS)

Meeting Abstract

D'Angelo, S.; Demetri, G.; Van Tine, B.; Druta, M.; Glod, J.; Chow, W.; Pandya, N.; Hasan, A.; Chiou, V.; Tress, J.; more...
Journal for ImmunoTherapy of Cancer (2020)

Fulltext@MSK | Save

Modeling the efficacy of NY-ESO-1 TCR T cells (letetresgene autoleucel; GSK3377794) in patients with synovial sarcoma: Correlations of response with transduced cell kinetics and biomarkers